218 related articles for article (PubMed ID: 28803179)
21. Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases.
Cabanie C; Biau J; Durando X; Mansard S; Molnar I; Chassin V; Verrelle P; Khalil T; Lapeyre M; Dupic G
Cancer Radiother; 2021 Jul; 25(5):432-440. PubMed ID: 33836954
[TBL] [Abstract][Full Text] [Related]
22. Management of Brain Metastases in Non-Small-Cell Lung Cancer.
Ernani V; Stinchcombe TE
J Oncol Pract; 2019 Nov; 15(11):563-570. PubMed ID: 31715122
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.
Reynolds C; Barrera D; Jotte R; Spira AI; Weissman C; Boehm KA; Pritchard S; Asmar L
J Thorac Oncol; 2009 Dec; 4(12):1537-43. PubMed ID: 19887966
[TBL] [Abstract][Full Text] [Related]
24. A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema.
Wang Y; Wang E; Pan L; Dai J; Zhang N; Wang X; Liu X; Mei G; Sheng X
J Neurooncol; 2014 Sep; 119(2):369-76. PubMed ID: 24879376
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary resection in patients with nonsmall-cell lung cancer treated with gamma-knife radiosurgery for synchronous brain metastases.
Yang SY; Kim DG; Lee SH; Chung HT; Paek SH; Hyun Kim J; Jung HW; Han DH
Cancer; 2008 Apr; 112(8):1780-6. PubMed ID: 18300239
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery.
Kong DS; Lee JI; Nam DH; Park K; Kim JH; Kim JG; Park JO; Park K
J Korean Med Sci; 2006 Jun; 21(3):527-32. PubMed ID: 16778400
[TBL] [Abstract][Full Text] [Related]
27. Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.
Takeda M; Yamanaka T; Seto T; Hayashi H; Azuma K; Okada M; Sugawara S; Daga H; Hirashima T; Yonesaka K; Urata Y; Murakami H; Saito H; Kubo A; Sawa T; Miyahara E; Nogami N; Nakagawa K; Nakanishi Y; Okamoto I
Cancer; 2016 Apr; 122(7):1050-9. PubMed ID: 26828788
[TBL] [Abstract][Full Text] [Related]
28. Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis.
Jawahar A; Matthew RE; Minagar A; Shukla D; Zhang JH; Willis BK; Ampil F; Nanda A
J Neurosurg; 2004 May; 100(5):842-7. PubMed ID: 15137603
[TBL] [Abstract][Full Text] [Related]
29. Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
Halasz LM; Uno H; Hughes M; D'Amico T; Dexter EU; Edge SB; Hayman JA; Niland JC; Otterson GA; Pisters KM; Theriault R; Weeks JC; Punglia RS
Cancer; 2016 Jul; 122(13):2091-100. PubMed ID: 27088755
[TBL] [Abstract][Full Text] [Related]
30. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
[TBL] [Abstract][Full Text] [Related]
31. Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089).
Barlesi F; Scherpereel A; Rittmeyer A; Pazzola A; Ferrer Tur N; Kim JH; Ahn MJ; Aerts JG; Gorbunova V; Vikström A; Wong EK; Perez-Moreno P; Mitchell L; Groen HJ
J Clin Oncol; 2013 Aug; 31(24):3004-11. PubMed ID: 23835708
[TBL] [Abstract][Full Text] [Related]
32. Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer.
Rades D; Huttenlocher S; Hornung D; Blanck O; Schild SE
BMC Cancer; 2014 Dec; 14():931. PubMed ID: 25496194
[TBL] [Abstract][Full Text] [Related]
33. The changing face of cancer treatments.
Keohane D; Fitzgerald GP
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30173128
[TBL] [Abstract][Full Text] [Related]
34. Combination of anti-PD-1 therapy and stereotactic radiosurgery for a gastric cancer patient with brain metastasis: a case report.
Ahn MJ; Lee K; Lee KH; Kim JW; Kim IY; Bae WK
BMC Cancer; 2018 Feb; 18(1):173. PubMed ID: 29433469
[TBL] [Abstract][Full Text] [Related]
35. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
Bougie E; Masson-Côté L; Mathieu D
World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic radiosurgery for the management of brain metastases.
Suh JH
N Engl J Med; 2010 Mar; 362(12):1119-27. PubMed ID: 20335588
[No Abstract] [Full Text] [Related]
37. [Advanced lung cancer with mediastinal lymph node metastasis and recurrence of brain metastasis completely responsive to combination chemotherapy and gamma knife radiosurgery--a case report].
Higaki N; Soma I; Hayashi N; Nakano K; Murakami M; Hayashida H; Kan K; Ichihara T; Aizawa N; Saito N; Niju T; Ikeda T; Sakon M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2111-3. PubMed ID: 20037340
[TBL] [Abstract][Full Text] [Related]
38. Study on lung cancer cells expressing VEGFR2 and the impact on the effect of RHES combined with radiotherapy in the treatment of brain metastases.
Jiang XD; Ding MH; Qiao Y; Liu Y; Liu L
Clin Lung Cancer; 2014 Mar; 15(2):e23-9. PubMed ID: 24374073
[TBL] [Abstract][Full Text] [Related]
39. Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC).
Andratschke N; Kraft J; Nieder C; Tay R; Califano R; Soffietti R; Guckenberger M
Lung Cancer; 2019 Mar; 129():63-71. PubMed ID: 30797493
[TBL] [Abstract][Full Text] [Related]
40. Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer.
Cho KR; Lee MH; Kong DS; Seol HJ; Nam DH; Sun JM; Ahn JS; Ahn MJ; Park K; Kim ST; Lim DH; Lee JI
J Neurooncol; 2015 Nov; 125(2):331-8. PubMed ID: 26373297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
